DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Imaging Market Analysis by Product and Service, by Modality, by Therapeutic Area, End user and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The clinical trial imaging market size is estimated to be USD 1.8 billion in 2021 and is expected to witness a CAGR of 9.47% during the forecast period 2022-2029. The rising number of CROs, escalating R&D spending, growing pharmaceutical and biotechnology industries are some of the key drivers for the market growth. However, high cost of implementation is expected to restrain the market growth.
Segmentation: Clinical Trial Imaging Market Report 2021-2029 Product & Service (Revenue, USD Billion)
- Software
- Services
By Modality (Revenue, USD Billion)
- Magnetic Resonance Imaging
- Positron Emission Tomography
- X-ray
- Ultrasound
- Computed Tomography
- Echocardiography
By Therapeutic Area (Revenue, USD Billion)
- Immunological Disorder
- Infectious Diseases
- Oncology
- CVS
- Endocrinology
- Neurology
By End user (Revenue, USD Billion)
- Biotechnology Companies
- Pharmaceutical Companies
- Academic and Government Research Institutes
- Medical Device Manufacturer
- Contract Research Organizations
By Region (Revenue, USD Billion)North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Clinical Trial Imaging
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Clinical Trial Imaging Market
7. Market Analysis by Production & Services
8. Market Analysis by Modality
9. Market Analysis by Therapeutic Area
10. Market Analysis by End user
11. Regional Market Analysis
12. North America Clinical Trial Imaging Market
13. Europe Clinical Trial Imaging Market
14. Asia Pacific Clinical Trial Imaging Market
15. Latin America Clinical Trial Imaging Market
16. MEA Clinical Trial Imaging Market
17. Competitor Analysis
18. Company Profiles
19. Conclusion & Recommendations
Companies Mentioned
- ICON plc. (Ireland)
- BioTelemetry Inc. (US)
- Biomedical Systems Corporation (US)
- Medpace Holdings Inc. (US)
- IXICO plc. (UK)
- Resonance Health Ltd. (Australia)
- Radiant Sage LLC. (US)
- BioClinica Inc. (US)
- Intrinsic Imaging LLC. (US)
- Cardiovascular Imaging Technologies LLC. (US)
- Medical Metrics Inc. (US)
- Prism Clinical Imaging Inc. (US)
- Boston Imaging Core Lab LLC. (US)
- anagram 4 clinical trials (Spain)
- Lyscaut Medical Imaging Company (Belgium)
- Calyx Group (UK)
- Bioseptive Inc. (Canada)
- ProScan Imaging LLC. (US)
- Micron Inc. (Japan)
- Imaging Endpoints LI LLC (US)
- Perspectum Ltd. (UK).
For more information about this report visit https://www.researchandmarkets.com/r/lxt0ri
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900